| Literature DB >> 36231640 |
Saleem Alhabash1, Yao Dong1, Charlotte Moureaud2, Iago S Muraro1, John B Hertig3.
Abstract
The increasing prevalence of online purchase of medications, specifically via social media platforms, poses significant health risks due to high chances of such medications being substandard and falsified (SF). The current study uses a 2 (persuasive appeal: fear vs. humor) x 3 (message repetition) mixed factorial experiment to investigate the effectiveness of persuasive appeals (on intentions to purchase medications online via social media referrals, mediated by psychological reactance (threat to freedom and anger), attitudes toward the public service announcements (PSAs), and viral behavioral intentions. ANOVA results showed the superiority of humor appeals compared to fear appeals in (1) reducing psychological reactance, (2) igniting favorable responses to the PSA, and (3) marginally reducing the intentions to purchase medications vial social media despite lower online engagement intentions (viral behavioral intentions). Pre-existing risk perceptions moderated these differences. A moderated serial mediation model, conducted using PROCESS models, was examined to assess the mechanism by which persuasive appeals and risk perceptions interact in influencing purchase intentions. Findings are discussed theoretically in regard to extending the psychological reactance model within the digital environment and practically in terms of public health, brand protection, and law enforcement recommendations.Entities:
Keywords: prescription medication; psychological reactance; risk perception; social media; substandard and falsified
Mesh:
Substances:
Year: 2022 PMID: 36231640 PMCID: PMC9564852 DOI: 10.3390/ijerph191912340
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Factor and reliability analysis results for all dependent variables.
| Statistic | Message 1 | Message 2 | Message 3 | |
|---|---|---|---|---|
| Eigenvalue | 2.56 | 2.62 | 2.56 | |
| % of Var. Exp. | 85.28% | 87.22 | 85.54% | |
| Factor Loadings | 0.919–0.928 | 0.932–0.935 | 0.923–0.928 | |
| Cronbach’s α | 0.914 | 0.927 | 0.915 | |
| Mean (SD) | 5.16 (1.59) | 4.92 (1.74) | 5.15 (1.59) | |
| Eigenvalue | 2.43 | 2.45 | 2.39 | |
| % of Var. Exp. | 80.94% | 81.76% | 79.63% | |
| Factor Loadings | 0.892–0.909 | 0.901–0.908 | 0.884–0.899 | |
| Cronbach’s α | 0.882 | 0.888 | 0.872 | |
| Mean (SD) | 5.21 (1.40) | 5.12 (1.45) | 5.14 (1.40) | |
| Eigenvalue | 1.99 | 2.05 | 1.98 | |
| % of Var. Exp. | 66.20% | 68.31% | 65.86% | |
| Factor Loadings | 0.759–0.855 | 0.769–0.855 | 0.726–0.858 | |
| Cronbach’s α | 0.739 | 0.762 | 0.731 | |
| Mean (SD) | 5.46 (1.15) | 5.43 (1.19) | 5.46 (1.15) | |
| Eigenvalue | 3.33 | 3.29 | 3.29 | |
| % of Var. Exp. | 83.36% | 82.36% | 82.33% | |
| Factor Loadings | 0.907–0.921 | 0.899–0.916 | 0.882–0.914 | |
| Cronbach’s α | 0.933 | 0.928 | 0.928 | |
| Mean (SD) | 4.55 (1.80) | 4.55 (1.78) | 4.56 (1.79) | |
| Eigenvalue | 3.57 | 3.52 | 3.59 | |
| % of Var. Exp. | 89.16% | 87.94% | 89.71% | |
| Factor Loadings | 0.940–0.947 | 0.932–0.944 | 0.943–0.950 | |
| Cronbach’s α | 0.959 | 0.954 | 0.962 | |
| Mean (SD) | 4.22 (2.00) | 4.29 (1.95) | 4.23 (1.98) | |
| Eigenvalue | 3.97 | 3.97 | 3.96 | |
| % of Var. Exp. | 79.47% | 79.30% | 79.28% | |
| Factor Loadings | 0.869–0.907 | 0.861–0.906 | 0.879–0.908 | |
| Cronbach’s α | 0.935 | 0.934 | 0.934 | |
| Mean (SD) | 4.94 (1.65) | 4.92 (1.64) | 5.00 (1.61) | |
| Eigenvalue | 3.60 | 3.60 | 3.58 | |
| % of Var. Exp. | 90.05% | 90.09% | 89.45% | |
| Factor Loadings | 0.941–0.958 | 0.942–0.957 | 0.936–0.955 | |
| Cronbach’s α | 0.963 | 0.963 | 0.961 | |
| Mean (SD) | 4.44 (2.07) | 4.41 (2.06) | 4.46 (2.07) |
Figure 1Percentage of participants who purchased medications on different platforms (top) and frequency of medication types purchased on different platforms (bottom).
Figure 2Means of major dependent variables, by persuasive appeal.
Figure 3Johnson-Neyman regions of significance with unstandardized beta coefficients for the effect of persuasive appeal on DVs at different values of risk perception (moderator). Values reported in the graph indicate unstandardized beta coefficients. Shaded area indicates significant regions.
Simple moderation analysis results for the effect of persuasive appeal on all DVs, moderated by risk perception.
| Predictor | T2F | Anger | APSA | VBI | PI |
|---|---|---|---|---|---|
| β (SE) [CILL−UL] | β (SE) [CILL−UL] | β (SE) [CILL−UL] | β (SE) [CILL−UL] | β (SE) [CILL−UL] | |
| constant | 4.33 (0.62) *** | 4.58 (0.70) *** | 3.91 (0.56) *** | 3.46 (0.60) *** | 5.50 (0.72) *** |
| Persuasive Appeal (PA) | 1.54 (0.60) * | 0.90 (0.67) | −0.87 (0.54) | 0.59 (0.58) | 0.50 (0.70) |
| Risk Perception (RP) | 0.06 (0.07) | −0.07 (0.08) | 0.15 (0.06) * | 0.23 (0.07) *** | −0.26 (0.08) *** |
| PA x RP | −0.35 (0.10) *** | −0.23 (0.12) † | 0.23 (0.09) * | −0.17 (0.10) † | −0.14 (0.12) |
| Gender | −0.23 (0.10)* | −0.23 (0.11) * | −0.27 (0.09) ** | 0.40 (0.10) *** | −0.30 (0.12) * |
| Age | 0.004 (0.005) | 0.01 (0.01) | −0.001 (0.004) | 0.01 (0.005) | 0.002 (0.006) |
| Prescription medication | −0.98 (0.12) *** | −0.99 (0.13)*** | −0.42 (0.11) *** | −0.34 (0.12) ** | 0.99 (0.14) *** |
| Health insurance | −0.12 (0.13) | −0.22 (0.14) | 0.23 (0.11) * | −0.20 (0.12) | −0.16 (0.15) |
| Education | 0.47 (0.06) *** | 0.52 (0.07) *** | 0.35 (0.05) *** | 0.40 (0.06) *** | 0.66 (0.07) *** |
| HH income | −0.26 (0.07) *** | −0.32 (0.08) *** | −0.14 (0.07) * | −0.24 (0.07) *** | −0.34 (0.09) *** |
|
| R = 0.49, R2 = 0.24, | R = 0.47, R2 = 0.22, | R = 0.39, R2 = 0.15, | R = 0.39, R2 = 0.15, | R = 0.50, R2 = 25, |
Notes. DVS = Dependent Variables; PA = Persuasive Appeal; RP = Risk Perception; T2F = Threat to Freedom; APSA = Attitudes toward the PSA; VBI = Viral Behavioral Intentions; PI = Purchase Intentions; † p ≤ 0.10, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
Figure 4Moderating effect of risk perception on T2F, Anger, APSA, and VBI.
Moderated serial mediation results for the effect of persuasive appeal on purchase intention, moderated by risk perception, and mediated serially by T2F, anger, Apsa, and VBI.
| Predictor | T2F β (SE) [CILL-UL] | Anger β (SE) [CILL-UL] | APSA β (SE) [CILL-UL] | VBI β (SE) [CILL-UL] | PI β (SE) [CILL-UL] |
|---|---|---|---|---|---|
| constant | 4.33 (0.62) *** | 0.16 (0.78) | 2.07 (1.00) * | 1.64 (1.00) | 0.78 (0.84) |
| PA | 1.54 (0.60) * | −0.49 (0.40) | −1.36 (0.51) ** | 0.81 (0.45) † | −0.13 (0.37) |
| RP | 0.06 (0.07) | −0.05 (0.11) | 0.20 (0.14) | −0.10 (0.15) | −0.43 *** (0.13) |
| PA x RP | −0.35 (0.10) *** | 0.09 (0.07) | 0.34 (0.09) *** | −0.22 (0.08) ** | 0.03 (0.07) |
| T2F | -- | 1.03 (0.16) *** | 0.71 (0.34) * | 0.83 (0.32) ** | −0.41 (0.26) |
| Anger | -- | -- | −0.30 (0.30) | −0.38 (0.27) | 0.07 (0.22) |
| APSA | -- | -- | -- | −0.01 (0.19) | 0.17 (0.18) |
| VBI | -- | -- | -- | -- | 1.26 (0.19) *** |
| T2F x RP | -- | −0.02 (0.02) | −0.06 (0.05) | −0.10 (0.05) * | 0.13 *** (0.04) |
| Anger x RP | -- | -- | 0.04 (0.05) | 0.08 (0.04) * | 0.03 (0.03) |
| APSA x RP | -- | -- | -- | 0.08 (0.03) ** | 0.02 (0.02) |
| VBI x RP | -- | -- | -- | -- | −0.15 *** (0.03) |
| Gender | −0.23 (0.10)* | −0.02 (0.07) | −0.19 (0.09)* | −0.18 (0.07) * | 0.02 (0.06) |
| Age | 0.004 (0.005) | 0.005 (0.003) | −0.003 (0.004) | 0.003 (0.004) | −0.003 (0.003) |
| Prescription med. | −0.98 (0.12) *** | −0.09 (0.08) | −0.11 (0.11) | 0.20 (0.09) * | −0.09 (0.07) |
| Health insurance | −0.12 (0.13) | −0.10 (0.08) | −0.18 (0.11) † | −0.02 (0.09) | 0.03 (0.08) |
| Education | 0.47 (0.06) *** | 0.08 *(0.04) * | 0.20 (0.05) *** | 0.07 (0.05) | 0.11 (0.04) |
| HH income | −0.26 (0.07) *** | −0.08 (0.05) | −0.06 (0.06) | −0.08 (0.05) | −0.03 (0.04) |
|
| R = 0.49, R2 = 0.24, | R = 0.85, R2 = 0.73, | R = 0.51, R2 = 0.26, | R = 0.71, R2 = 0.51, | R = 0.90, R2 = 0.81, |
|
|
| ||||
|
|
|
| |||
|
|
|
| |||
| PA → T2F → PI | −0.02 (0.03) [−0.09, 0.04] |
|
| ||
| PA → Anger → PI | −0.01 (0.02) [−0.06, 0.02] | 0.01 (0.02) [−0.03, 0.06] | 0.04 (0.04) [−0.03, 0.13] | ||
| PA → APSA → PI | 0.06 (0.03) [0.003, 0.14] |
|
| ||
| PA → VBI → PI |
|
|
| ||
| PA → T2F → Anger → PI | −0.02 (0.03) [−0.07, 0.03] |
|
| ||
| PA → T2F → APSA → PI | −0.01 (0.02) [−0.05, 0.02] |
|
| ||
| PA → T2F → VBI → PI | −0.02 (0.03) [−0.09, 0.03] |
| −0.02 (0.02) [−0.06, 0.02] | ||
| PA → Anger → APSA → PI | 0.002 (0.004) [−0.004, 0.01] | −0.001 (0.002) [−0.005, 0.003] | 0.0002 (0.005) [−0.01, 0.01] | ||
| PA → Anger → VBI → PI | −0.001 (0.006) [−0.02, 0.01] | 0.002 (0.004) [−0.01, 0.01] | 0.006 (0.007) [−0.01, 0.02] | ||
| PA → T2F → Anger → APSA → PI | 0.002 (0.005) [−0.01, 0.01] | 0.01 (0.01) [−0.01, 0.02] | −0.001 (0.02) [−0.05, 0.04] | ||
| PA → T2F → Anger → VBI → PI | −0.001 (0.001) [−0.02, 0.02] |
|
| ||
| PA → T2F → APSA → VBI → PI | −0.01 (0.01) [−0.03, 0.01] |
|
| ||
| PA → Anger → APSA → VBI → PI | 0.001 (0.003) [−0.003, 0.001] | −0.0003 (0.001) [−0.003, 0.002] | 0.0001 (0.002) [−0.003, 0.01] | ||
| PA → T2F → Anger → APSA → VBI → PI | 0.002 (0.004) [−0.004, 0.01] | 0.003 (0.01) [−0.01, 0.01] | −0.001 (0.01) [−0.02, 0.02] | ||
Notes. PA = Persuasive Appeal; RP = Risk Perception; T2F = Threat to Freedom; APSA = Attitudes toward the PSA; VBI = Viral Behavioral Intentions; PI = Purchase Intentions; † p ≤ 0.10 * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001; a bolded indirect effects indicate significant effect as confidence interval does not include a true zero.
Figure 5Moderated serial mediation of the effect of persuasive appeal on PI, moderated by risk perceptions.